TPO and kidney disorder: In a mouse model of antibody-mediated chronic kidney disease (AMCKD), renal-derived thrombopoietin (TPO) boosts the production of myeloid cells and platelets, aggravating chronic thromobinflammation in the microvasculature, and TPO neutralization can ameliorate this kidney disease (54).